13.07.2015 Views

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Fresenius <strong><strong>Bio</strong>tech</strong> GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Immune Therapy, Antibody Therapy, Oncology,Transplantation, Stem CellFresenius <strong><strong>Bio</strong>tech</strong> GmbH is a globally operating company dedicated todelivering biopharmaceutical treatment options in oncology and transplantationmedicine. A focal point of activity is the development and commercializationof immunologically active biopharmaceutical therapeutics based on innovativeantibody technologies.The company currently has two drugs on themarket: Removab in Oncology and ATG Fresenius-S in solid organ and stem celltransplantation. Fresenius <strong><strong>Bio</strong>tech</strong> GmbH is a subsidiary of the Fresenius SEhealthcare group. For further details please visit www.fresenius-biotech.com.Contact:Dr. Christian SchetterFrankfurter Ring 193aD-80807 MünchenPhone: +49 (0) 89 306593-0Fax: +49 (0) 89 306593-292E-Mail: info@fresenius-biotech.comInternet: www.fresenius-biotech.comFRIZ <strong>Bio</strong>chem Gesellschaft für<strong>Bio</strong>analytik mbHBIOTECH DEVICES & REAGENTSKeywords: Clinical Diagnostics, Devices, Infectious Diseases, Chip / ArrayTechnologyFRIZ <strong>Bio</strong>chem develops and produces highly reliable user-friendly and inexpensivebiochip systems for applications in medical diagnostics, foodtesting and pharmaceutical research. Key products are DNA-chips withdirect electrical read-out where SNPs (single nucleotide polymorphism) canunambiguously be detected and time-consuming labeling of the target-DNAis no longer necessary. This enables a broad range of simple and fast analysesmaking the system ideal for biological medical studies.The company’s proprietary combination of micro arrays, electrical detectionand semiconductor technology opens the way to compact multiplex analysesdirectly at a PC without the expensive instrumentation commonly needed.Contact:Dr. Gerhard HartwichFloriansbogen 2-4D-82061 NeuriedPhone: +49 (0) 89 724409-0Fax: +49 (0) 89 724409-10E-Mail: info@frizbiochem.deInternet: www.frizbiochem.deGE Healthcare Europe GmbHBIOTECH DEVICES & REAGENTSKeywords: Fine Chemicals / Reagents, Devices, Analytical Chemistry,Genomics, ProteomicsGE Healthcare Life Sciences provides a broad range of products and servicesfor biomolecule separations at all scales. Chief products include:ÄKTAdesign chromatography systems and <strong>Bio</strong>Process mediaFiltration systems and devices Wave <strong>Bio</strong>reactor and mixersCell separation for isolating and purifying cells, viruses, and sub-cellularparticles Fast Trak <strong>Bio</strong>Pharma Services.Our products are used in the manufacture of the majority of all FDA-approvedbiopharmaceuticals on the market. GE Healthcare Life Sciences is a partof GE Healthcare, a General Electric company with more than 42,000employees, providing transformational medical technologies that are shapinga new age of patient care.Contact:Michael KalejaOskar-Schlemmer-Str. 11D-80807 MünchenPhone: +49 (0) 8996 281-690Fax: +49 (0) 8996 281-679E-Mail: michael.kaleja@ge.comInternet: www.gelifesciences.com63

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!